Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

키워드

참고문헌 (58)

1. Choo SP, "Comparison of hepatocellular carcinoma in Eastern versus Western populations", Cancer, 122, pp.3430~3446 (2016)
2. Akinyemiju T, "The burden of primary liver cancer and underlying etiologies from 1990 to 2015at the global, regional, and national level : results from the global burden of disease study 2015", JAMA Oncol, 3, pp.1683~1691 (2017)
3. Shields A, "Hepatocellular carcinoma : current treatment strategies", Curr Treat Options Gastroenterol, 8, pp.457~466 (2005)
4. Heimbach JK, "AASLD guidelines for the treatment of hepatocellular carcinoma", Hepatology, 67, pp.358~380 (2018)
5. Tang A, "Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ", Abdom Radiol(NY), 43, pp.3~12 (2018)
6. Tang A, "Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI", Expert Rev Gastroenterol Hepatol, 7, pp.269~279 (2013)
7. Gavriilidis P, "Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument", J Hepatol, 67, pp.991~998 (2017)
8. Omata M, "Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma : a 2017 update", Hepatol Int, 11, pp.317~370 (2017)
9. "Liver Imaging Reporting and Data System version 2017"[URL]
10. "Liver Imaging Reporting and Data System version 2018"[URL]
11. Marrero JA, "Diagnosis, staging and management of hepatocellular carcinoma : 2018 practice guidance by the American Association for the Study of Liver Diseases", Hepatology, 68, pp.723~750 (2018)
12. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
13. "2018 KLCA-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma"[URL]
14. Cruite I, "Imaging-based diagnostic systems for hepatocellular carcinoma", AJR Am J Roentgenol, 201, pp.41~55 (2013)
15. "Ultrasound LI-RADS(R) v2017"[URL]
16. Dulku G, "The role of imaging in the surveillance and diagnosis of hepatocellular cancer", J Med Imaging Radiat Oncol, 61, pp.171~179 (2017)
17. Singal A, "Meta-analysis : surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis", Aliment Pharmacol Ther, 30, pp.37~47 (2009)
18. Tzartzeva K, "Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis : a meta-analysis", Gastroenterology, 154, pp.1706~1718 (2018)[DOI]
19. Chernyak V, "LI-RADS(R) algorithm:CT and MRI", Abdom Radiol(NY), 43, pp.111~126 (2018)
20. Kitao A, "The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis : correlation with gadoxetic acid enhanced MR imaging", Eur Radiol, 21, pp.2056~2066 (2011)
21. Kogita S, "Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma : correlation with histological grading and portal blood flow", Eur Radiol, 20, pp.2405~2413 (2010)
22. Lee YJ, "Hepatocellular carcinoma : diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis", Radiology, 275, pp.97~109 (2015)
23. Kim TK, "Contrast-enhanced ultrasound(CEUS)liver imaging reporting and data system(LI-RADS)2017-a review of important differences compared to the CT", MRI system, 2017, pp.23, 280~289
24. Leoni S, "Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound : which vascular criteria should be adopted", Ultraschall Med, 34, pp.280~287 (2013)
25. Furlan A, "Enhancement pattern of small hepatocellular carcinoma(HCC)at contrast-enhanced US(CEUS), MDCT, and MRI : intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases(AASLD)guidelines", Eur J Radiol, 81, pp.2099~2105 (2012)
26. Forner A, "Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis : prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma", Hepatology, 47, pp.97~104 (2008)
27. Piscaglia F, "Diagnosis of hepatocellular carcinoma with non-invasive imaging : a plea for worldwide adoption of standard and precise terminology for describing enhancement criteria", Ultraschall Med, 38, pp.9~11 (2017)
28. Piscaglia F, "American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System(CEUS LI-RADS)for the diagnosis of hepatocellular carcinoma : a pictorial essay", Ultraschall Med, 38, pp.320~324 (2017)
29. Chen LD, "Intrahepatic cholangiocarcinoma and hepatocellular carcinoma : differential diagnosis with contrast-enhanced ultrasound", Eur Radiol, 20, pp.743~753 (2010)
30. Claudon M, "Guidelines and good clinical practice recommendations for contrast enhanced ultrasound(CEUS)in the liver--update 2012 : a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS", Ultraschall Med, 34, pp.11~29 (2013)
31. Wildner D, "CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients-early or late washout matters : a subanalysis of the DEGUM multicenter trial", Ultraschall Med, 36, pp.132~139 (2015)
32. Wildner D, "Dynamic contrast-enhanced ultrasound(DCE-US)for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma", Ultraschall Med, 35, pp.522~527 (2014)
33. Terzi E, "Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1, 006nodules", J Hepatol, 68, pp.485~492 (2018)
34. Aubé C, "EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice", Liver Int, 37, pp.1515~1525 (2017)
35. Bota S, "Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma", Liver Cancer, 1, pp.190~200 (2012)
36. Kudo M, "Defect reperfusion imaging with Sonazoid(R) : a breakthrough in hepatocellular carcinoma", Liver Cancer, 5, pp.1~7 (2016)
37. Jang HJ, "CEUS : an essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma", Eur J Radiol, 84, pp.1623~1635 (2015)
38. Farinati F, "Early and very early hepatocellular carcinoma : when and how much do staging and choice of treatment really matter? A multi-center study", BMC Cancer, 9, pp.33~ (2009)
39. Wald C, "New OPTN", UNOS policy for liver transplant allocation : standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma, 2013, pp.266, 376~382
40. Joo I, "Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI : can hypointensity on the hepatobiliary phase be used as an alternative to washout", Eur Radiol, 25, pp.2859~2868 (2015)
41. Choi SH, "Diagnostic criteria for hepatocellular carcinoma 3 cm with hepatocytespecific contrast-enhanced magnetic resonance imaging", J Hepatol, 64, pp.1099~1107 (2016)
42. Kierans AS, "The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm : a meta-analysis", Radiology, 278, pp.82~94 (2016)
43. Joo I, "Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI : can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features", Eur Radiol, 29, pp.1724~1732 (2019)
44. Maruyama H, "Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma : evidence from a 10-year experience", J Gastroenterol, 51, pp.421~433 (2016)
45. Hatanaka K, "Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT", Oncology, 75(Suppl 1), pp.42~47 (2008)
46. Liu W, "Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS", Acta Radiol, 59, pp.140~146 (2018)
47. Kim YY, "Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System(LI-RADS)in gadoxetate-enhanced MRI", Eur Radiol, 28, pp.2038~2046 (2018)
48. Abd Alkhalik Basha M, "Diagnostic efficacy of the Liver Imaging-Reporting and Data System(LI-RADS)with CT imaging in categorising small nodules(10-20mm)detected in the cirrhotic liver at screening ultrasound", Clin Radiol, 72, pp.901.e1~901.e11 (2017)
49. Sofue K, "Liver imaging reporting and data system category 4observations in MRI : risk factors predicting upgrade to category 5", J Magn Reson Imaging, 46, pp.783~792 (2017)
50. Tanabe M, "Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging", Radiology, 281, pp.129~139 (2016)
51. Burke LM, "Natural history of liver imaging reporting and data system category 4 nodules in MRI", Abdom Radiol(NY), 41, pp.1758~1766 (2016)
52. Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
53. Zhang J, "Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma : a meta-analysis with evidence from 1998 to 2016", Oncotarget, 8, pp.75418~75426 (2017)
54. Mitchell DG, "LI-RADS(Liver Imaging Reporting and Data System) : summary, discussion, and consensus of the LI-RADS Management Working Group and future directions", Hepatology, 61, pp.1056~1065 (2015)
55. Jang KM, "Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease", Acta Radiol, 56, pp.526~535 (2015)
56. Song KD, "Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma : natural course on serial gadoxetic acid-enhanced MRI and diffusionweighted imaging", Eur Radiol, 25, pp.2789~2796 (2015)
57. Wang JH, "The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients", Eur J Cancer, 44, pp.1000~1006 (2008)
58. Joo I, "Recent advances in the imaging diagnosis of hepatocellular carcinoma : value of gadoxetic acid-enhanced MRI", Liver Cancer, 5, pp.67~87 (2016)

관련 논문AI추천